Senna (Senna)



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 25.0%
Blood Cholesterol Increased 12.5%
Constipation 12.5%
Depression 12.5%
Hypertension 12.5%
Schizophrenia 12.5%
Type 2 Diabetes Mellitus 12.5%
White Blood Cell Count Increased 66.7%
Blood Pressure Systolic Increased 16.7%
Victim Of Homicide 16.7%
Concomitant
Multiple Myeloma 52.3%
Acute Myeloid Leukaemia 8.1%
Non-small Cell Lung Cancer 7.2%
Lymphoma Aids Related 6.1%
Small Cell Lung Cancer Stage Unspecified 2.6%
Glioblastoma 2.3%
Lung Neoplasm Malignant 2.0%
Myelodysplastic Syndrome 2.0%
Renal Cell Carcinoma Stage Unspecified 2.0%
Pain 1.7%
Pancreatic Carcinoma Metastatic 1.7%
Depression 1.4%
Drug Use For Unknown Indication 1.4%
Macular Oedema 1.4%
Pancreatic Carcinoma 1.4%
Prophylaxis Against Transplant Rejection 1.4%
Anaplastic Large Cell Lymphoma T- And Null-cell Types 1.2%
Anaplastic Large-cell Lymphoma, Primary Systemic Type 1.2%
Anxiety 1.2%
Breast Cancer 1.2%
White Blood Cell Count Decreased 12.0%
Thrombocytopenia 8.7%
Vomiting 8.7%
Rash 5.4%
Syncope 5.4%
Transient Ischaemic Attack 5.4%
Ventricular Tachycardia 5.4%
Angina Unstable 4.3%
Metastases To Liver 4.3%
Pain 4.3%
Pancytopenia 4.3%
Pneumonia 4.3%
Urinary Retention 4.3%
Fatigue 3.3%
Multiple Myeloma 3.3%
Neuropathy Peripheral 3.3%
Perforated Ulcer 3.3%
Platelet Count Decreased 3.3%
Pleural Effusion 3.3%
Pneumaturia 3.3%